The majority of drugs used to treat asthma today are the same ones that were used 50 years ago. Tissue-level model of human airway musculature could pave way for patient-specific asthma treatments
New drugs are urgently needed to treat this chronic respiratory disease, which causes nearly 25 million people in the United States alone to wheeze, cough, and find it difficult at best to take a deep breath.
But finding new treatments is tough: asthma is a patient-specific disease, so what works for one person doesn’t necessarily work for another, and the animal models traditionally used to test new drug candidates often fail to mimic human responses–costing tremendous money and time.
Hope for healthier airways may be on the horizon thanks to a Harvard University team that has developed a human airway muscle-on-a-chip that could be used to test new drugs because it accurately mimics the way smooth muscle contracts in the human airway, under normal circumstances and when exposed to asthma triggers. As reported in the journal Lab on a Chip, it also offers a window into the cellular and even subcellular responses within the tissue during an asthmatic event.
“Every year asthma costs many tens of billions of dollars, significant productivity due to lost work and school days, and even lives,” said senior author Kevin Kit Parker, Ph.D., a Core Faculty member at Harvard’s Wyss Institute for Biologically Inspired Engineering and Tarr Family Professor of Bioengineering and Applied Physics at the Harvard School of Engineering and Applied Sciences (SEAS). Parker leads development of the Wyss Institute’s heart-on-a-chip technology as well and is specifically interested in diseases that affect children. “We were thrilled with how well the chip recapitulated the functioning of the human airway.”
The chip, a soft polymer well that is mounted on a glass substrate, contains a planar array of microscale, engineered human airway muscles, designed to mimic the laminar structure of the muscular layers of the human airway.
To mimic a typical allergic asthma response, the team first introduced interleukin-13 (IL-13) to the chip. IL-13 is a natural protein often found in the airway of asthmatic patients that mediates the response of smooth muscle to an allergen.
Then they introduced acetylcholine, a neurotransmitter that causes smooth muscle to contract. Sure enough, the airway muscle on the chip hypercontracted – and the soft chip curled up – in response to higher doses of the neurotransmitter.
They achieved the reverse effect as well and triggered the muscle to relax using drugs called ?-agonists, which are used in inhalers.
Significantly, they were able to measure the contractile stress of the muscle tissue as it responded to varying doses of the drugs, said lead author Alexander Peyton Nesmith, a Ph.D./M.D. student at Harvard SEAS and the University of Alabama at Birmingham. “Our chip offers a simple, reliable and direct way to measure human responses to an asthma trigger,” he said.
The Latest on: Asthma
via Google News
The Latest on: Asthma
- In Detroit, ‘revolutionary’ mapping could help residents with asthmaon August 18, 2019 at 1:02 am
This story was originally published by Undark Magazine and is reproduced here as part of the Climate Desk collaboration. Much of Detroit is in ruins. The city spreads over 139 square miles, but ...
- Children with mild asthma can use inhalers to effectively manage the conditionon August 18, 2019 at 12:42 am
A new study from Washington University School of Medicine in St. Louis supports evidence that children with mild asthma can effectively manage the condition by using their two inhalers - one a steroid ...
- Children with mild asthma can use inhalers as needed, study suggestson August 16, 2019 at 5:07 pm
A new study supports evidence that children with mild asthma can effectively manage the condition by using their two inhalers -- one a steroid and the other a bronchodilator -- when symptoms occur.
- Multidisciplinary Team Explores Link Between Asthma and Depressionon August 16, 2019 at 1:47 pm
In a first-of-its-kind study, researchers from the Icahn School of Medicine at Mount Sinai, Montefiore Health System, and Albert Einstein College of Medicine are working together to examine the link ...
- On summer challenges of severe asthma patientson August 15, 2019 at 12:58 pm
A sense of victory by both Hamas and Israel: A recipe for escalation in Gaza?
- A descriptive follow-up interview study assessing patient-centred outcomes: Salford Lung Study in Asthma (SLS Asthma)on August 15, 2019 at 3:00 am
The Salford Lung Study in Asthma (SLS Asthma) was a multicentre, randomised, controlled, open-label trial that assessed initiating once-daily, single-inhaler fluticasone furoate/vilanterol (FF/VI) 100 ...
- Attacking asthma in kidson August 14, 2019 at 10:42 am
According to the World Health Organization, asthma is the most prevalent chronic childhood disease worldwide. That's why researchers are working on developing technology that could predict when a ...
- Rethinking urban trees: Canopy not a cure-all for air pollution, asthmaon August 13, 2019 at 4:38 pm
WORCESTER - They provide shade, cooling streets and reducing energy costs. They absorb storm water, benefit mental health and even reduce crime. But the much-touted conventional wisdom that urban ...
- First-Of-Its-Kind Research Examines The Relationship Between Asthma Rates, Disease Control And Depressionon August 13, 2019 at 12:37 pm
$3.4 Million Study to Understand Why Older Adults Have Worse Asthma Outcomes NEW YORK, Aug. 13, 2019 /PRNewswire/ -- Asthma is underdiagnosed and undertreated in older Americans, leading to poor ...
- Evidence for a link between the Atlantic Multidecadal Oscillation and annual asthma mortality rates in the USon August 12, 2019 at 2:40 pm
An association between climatic conditions and asthma mortality has been widely assumed. However, it is unclear whether climatic variations have a fingerprint on asthma dynamics over long time ...
via Bing News